Patents Assigned to University of Miami
  • Patent number: 8198099
    Abstract: Semiconductor quantum dots are becoming valuable analytical tools for use in biomedical applications. Indeed, their unique properties offer the opportunity to design luminescent probes for imaging and sensing with unprecedented performance. In this context, we have identified operating principles to transduce supramolecular association of complementary receptor-ligand binding pairs into enhancement or suppression in the luminescence of sensitive quantum dots. Thus, complementary receptor-ligand binding pairs can be identified with luminescence measurements relying on our design logic. In fact, we have demonstrated with a representative example that our protocol can be adapted to signal receptor-ligand binding.
    Type: Grant
    Filed: July 9, 2007
    Date of Patent: June 12, 2012
    Assignee: The University of Miami
    Inventors: Francisco M. Raymo, Massimilliano Tomasulo, Ibrahim Yildiz
  • Publication number: 20120142544
    Abstract: Molecular signatures that function as very sensitive diagnostic biomarker for myocarditis, heart disease and disorders thereof, are identified.
    Type: Application
    Filed: June 2, 2010
    Publication date: June 7, 2012
    Applicant: University of Miami
    Inventors: Joshua M. Hare, Bettina Heidecker
  • Publication number: 20120135011
    Abstract: Compositions specific for TNF-receptor superfamily member 25 (TNFRSF25, DR3) modulate the immune response by regulating T regulatory cells.
    Type: Application
    Filed: August 3, 2010
    Publication date: May 31, 2012
    Applicant: UNIVERSITY OF MIAMI
    Inventors: Eckhard R. Podack, Taylor Schreiber, Dietlinde-Maria Wolf
  • Publication number: 20120129199
    Abstract: Nanoparticle-based compositions, assays, kits, methods and platforms for delivering an antigen (peptides, proteins) or a nucleic acid encoding an antigen to professional APCs (PAPCs) result in the generation of autologous APCs that present a natural peptide repertoire of the antigen for use in assessing the efficacy of a vaccine (e.g., a cytotoxic T lymphocyte (CTL) response to a particular antigen) or other therapy or intervention (cell-based therapy, adjuvant therapy, etc.). The compositions, kits, assays and methods also can be used for delivering a drug or biologic or portion thereof to APCs for assessing the immunogenicity of drugs and biologics. The composition, kits, assays and methods involve the combined use of MHC targeting, universal DR binding peptides (e.g., PADRE, HA) with charged (e.g., positively-charged) highly branched polymeric dendrimers (e.g.
    Type: Application
    Filed: May 19, 2010
    Publication date: May 24, 2012
    Applicant: UNIVERSITY OF MIAMI
    Inventors: Pirouz M. Daftarian, Paolo Serafini, Vance Paul Lemmon, Angel Kaifer, Bonnie Beth Blomberg, Raquibul Chowdhury, Norma Kenyon
  • Publication number: 20120115165
    Abstract: Novel, sensitive and specific markers and methods for diagnostics and monitoring of head and neck squamous cell carcinoma (HNSCC) are provided. Kits and methods for the use of hyaluronic acid, hyaluronidase and CD44 to diagnose HNSCC are described.
    Type: Application
    Filed: December 13, 2011
    Publication date: May 10, 2012
    Applicant: UNIVERSITY OF MIAMI
    Inventors: Elizabeth J. Franzmann, Vinata B. Lokeshwar
  • Publication number: 20120114729
    Abstract: A composite for delivering extended-release of oxygen is disclosed. The composite can include a biocompatible polymeric support having a plurality of solid peroxide particles suspended therein. The polymer support can exhibit an oxygen tension value of at least 40 mmHg for a period of 14 days. The weight ratio of biocompatible polymeric support to solid peroxide particles can range from 1:1 to 99:1. Also disclosed is a method of using the composite to deliver oxygen to cells in both in vivo and in vitro environments.
    Type: Application
    Filed: April 15, 2010
    Publication date: May 10, 2012
    Applicant: UNIVERSITY OF MIAMI
    Inventors: Cherie L. Stabler, Benjamin S. Harrisson, Christopher A. Fraker, Eileen Pedrada, Camillo Ricordi
  • Publication number: 20120101375
    Abstract: A method of thermally inducing and monitoring changes to localized regions of tissue illuminating a volume of tissue with a first beam of X-rays, detecting portions of the first beam that passed through the volume, generating a first image signal from the portions of the first beam detected, applying heat to at least a localized region of tissue within the volume after the illuminating and detecting, illuminating the volume with a second beam of X-rays, detecting portions of the second beam that passed through the volume during the illuminating with the second beam, generating a second image signal from the portions of the second beam detected, and generating a difference image signal based upon a comparison of the first and second image signals. The difference image signal provides information of changes in X-ray attenuation by localized regions of tissue within the volume due to the application of heat.
    Type: Application
    Filed: November 4, 2011
    Publication date: April 26, 2012
    Applicant: University of Miami
    Inventors: Jean-Marie Parel, Fabrice Manns, David S. Robinson, Peter Milne, David B. Denham, Xochitl Gonzalez-Cirre
  • Publication number: 20120093761
    Abstract: Nanoparticle-based vaccines, compositions, kits and methods are used for the effective delivery of one or more antigens in vivo for vaccination and antibody (e.g., monoclonal antibody) production, and for the effective delivery of peptides, proteins, siRNA, RNA or DNA to PAPCs or MHC class II positive cells (e.g. tumor cells). Antigens may be, for example, DNA that results in expression of the gene of interest and induction of a robust and specific immune response to the expressed protein in a subject (e.g., mammal). Antigens may also be immunogenic peptides or polypeptides that are processed and presented. In one embodiment, a nanoparticle -based method to deliver antigens in vivo as described herein includes injection of a vaccine composed of a DNA encoding at least one antigen, or at least one antigenic peptide or polypeptide conjugated to a charged dendrimer (e.g., PADRE-derivatized dendrimer) that is also conjugated to a T helper epitope (e.g., PADRE).
    Type: Application
    Filed: April 1, 2010
    Publication date: April 19, 2012
    Applicant: UNIVERSITY OF MIAMI
    Inventors: Pirouz M. Daftarian, Paolo Serafini, Vance Paul Lemmon, Angel Kaifer, Victor L. Perez, Wei Li, Bonnie Beth Blomberg
  • Publication number: 20120088739
    Abstract: A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
    Type: Application
    Filed: December 1, 2011
    Publication date: April 12, 2012
    Applicant: THE UNIVERSITY OF MIAMI
    Inventors: Stephen C. Pflugfelder, Balakrishna L. Lokeshwar, Marie Selzer
  • Patent number: 8156168
    Abstract: A method, system and apparatus that advantageously provide a security protocol for data security. The apparatus includes a random number generator for generating random numbers and a share calculator in communication with the random number generator, the share calculator processes the data to generate one or more encoded data shares where the processing is based at least in part on the random numbers. The apparatus may further include a router that routes the encoded data shares, a switching fabric and associated logic. The data security system includes one or more storage devices that store client data and a splitter that controls access to the client data stored on the one or more storage devices where the splitter apparatus encodes at least a portion of the client data that is stored on the one or more storage devices.
    Type: Grant
    Filed: August 16, 2007
    Date of Patent: April 10, 2012
    Assignee: University of Miami
    Inventor: Burton J. Rosenberg
  • Patent number: 8153436
    Abstract: Methods of assaying for disease-associated crystal species in biological samples are described. Such methods involve contacting a patient sample with an excess of a detectable crystal-tagging compound reactive with a plurality of crystal species under conditions that allow the detectable crystal-tagging compound to react with a plurality of crystal species, if present, to form tagged crystal species complexes. Substantially all unreacted tagging compound is then removed. If desired, chemical, enzymatic, or physical treatment can be used to selectively degrade some, but not, of the tagged crystal species. Assessment of soluble versus crystal-associated label is then performed.
    Type: Grant
    Filed: February 14, 2008
    Date of Patent: April 10, 2012
    Assignees: The United States of America as represented by the Department of Veterans Affairs, University of Miami
    Inventor: Herman S. Cheung
  • Patent number: 8147825
    Abstract: Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals.
    Type: Grant
    Filed: January 21, 2005
    Date of Patent: April 3, 2012
    Assignee: University of Miami
    Inventors: Sung Lan Hsia, Niven Rajin Narain, Jie Li, Kathryn J. Russell, Karrune V. Woan, Indushekhar Persaud
  • Publication number: 20120070511
    Abstract: Compositions which modulate mitochondrial functions treat diseases associated with cells that are hyperactively using their endoplasmic reticulum. Screening assays identify agents which modulate mitochondrial functions.
    Type: Application
    Filed: September 21, 2011
    Publication date: March 22, 2012
    Applicant: UNIVERSITY OF MIAMI
    Inventors: Theodore Lampidis, Metin Kurtoglu
  • Publication number: 20120071911
    Abstract: A method and device for occluding an aneurysm. The device may include a wire having a shape memory. The wire may define a coil. The wire may further define a first substantially spherical helix and a second substantially spherical helix nested within the first substantially spherical helix. A catheter may be included, being releaseably engageable to the wire, the wire being at least partially disposed within the catheter.
    Type: Application
    Filed: May 20, 2009
    Publication date: March 22, 2012
    Applicant: UNIVERSITY OF MIAMI
    Inventors: Chandramouli Sadasivan, Baruch B Lieber
  • Publication number: 20120055810
    Abstract: A method and system for corrosion detection. The system may comprise an electrochemical sensor having a working electrode, a reference electrode, a counter electrode, and a polymer electrolyte film containing redox pairs. The electrochemical sensor may further be engaged with a guide element. A console may be included, the console being coupled to the guide element and in electrical communication with the electrochemical sensor.
    Type: Application
    Filed: May 29, 2009
    Publication date: March 8, 2012
    Applicant: UNIVERSITY OF MIAMI
    Inventor: Xiangyang Zhou
  • Publication number: 20120037751
    Abstract: A bidirectional flying wing maximizes efficiency and reduces sonic boom during supersonic flight. The flying wing has bilateral symmetry across two perpendicular planes and a substantially isentropic compression bottom surface that minimizes the shock wave projected downward during flight. The flying wing may be rotated to provide a high aspect ratio and a low sweep angle during subsonic flight. The flying wing may be rotated to provide a low aspect ratio and a high sweep angle during supersonic flight.
    Type: Application
    Filed: April 26, 2010
    Publication date: February 16, 2012
    Applicant: UNIVERSITY OF MIAMI
    Inventor: GeCheng Zha
  • Publication number: 20120027670
    Abstract: A method and system for the reduction of pollutant NOx gases from automobile exhaust, as well as a method of reforming hydrocarbons, using a self-sustaining catalyst comprising an ion conductive support, a dispersed cathodic phase, a dispersed anodic phase, and a dispersed sacrificial phase, and a method of forming the self-sustaining catalyst.
    Type: Application
    Filed: April 6, 2010
    Publication date: February 2, 2012
    Applicant: University of Miami
    Inventor: Xiangyang Zhou
  • Publication number: 20120029472
    Abstract: TNFR25 compositions enhance the immune response against antigens. Administration of TNFR25 agonists was found to enhance tumor rejection, responses against viral diseases and other infectious organisms.
    Type: Application
    Filed: December 21, 2009
    Publication date: February 2, 2012
    Applicant: University of Miami
    Inventors: Eckhard R. Podack, Natasa Strbo, Vadim Deyev, Taylor Schreiber
  • Patent number: 8105632
    Abstract: Compositions comprising membrane-derived and synthetic microparticles that induce platelet aggregation and are useful for treating bleeding disorders, particularly those involving platelet dysfunction. Microparticles include endothelial derived microparticles (EMP), platelet derived microparticles (PMP), erythrocyte derived microparticles (RMP), and synthetic microparticles (SMP), and are used to treat disorders such as thrombocytopenia caused by chemotherapy.
    Type: Grant
    Filed: December 7, 2005
    Date of Patent: January 31, 2012
    Assignee: University of Miami
    Inventors: Wenche Jy, Joaquin J. Jimenez, Lawrence L. Horstmann, Yeon S. Ahn, Eugene Ahn
  • Patent number: 8097033
    Abstract: A prosthetic device and method to restore extraocular muscle function. The device includes a housing; a biasing component disposed in the housing; a proximal connector operatively connected to a proximal end of the biasing component; and a distal connector operatively connected to a distal end of the biasing component, wherein the proximal connector is configured for being secured with respect to an orbital bone and the distal connector adapted to be secured to the paralyzed or absent muscle stump, e.g. on the globe, or to the eyelid.
    Type: Grant
    Filed: June 13, 2006
    Date of Patent: January 17, 2012
    Assignee: The University of Miami
    Inventor: David T. Tse